Your fact-checks will appear here
Species of fish
Early evidence shows 2025–26 flu vaccines likely cut medically attended illness and hospitalizations roughly in half in settings where the same viruses circulated as in the Southern Hemisphere (about ...
Public reporting does not give a single, agreed total number of people who have died “from” COVID-19 vaccines; recent U.S. agency reviews say at least 10 children were judged related to vaccination in...
Available sources report that common COVID-19 vaccine side effects — sore arm, fatigue, fever, chills, headache and muscle aches — are usually brief, often resolving within 1–2 days after vaccination ...
Available reporting shows common COVID-19 vaccine reactions are short-lived (sore arm, fever, fatigue that usually resolve in 1–2 days) and that serious, long-term adverse events linked to vaccines ha...
Common short-term side effects after COVID-19 vaccination — pain at the injection site, fatigue, headache, muscle aches, chills and fever — typically appear within a day and resolve within a few days ...
Legal and regulatory definitions and policy treatments of “vaccine” in the United States have shifted from broad, program-driven public‑health mandates toward more product‑and‑risk‑based and individua...
Dr. David E. Martin is a public figure who has repeatedly presented claims challenging mainstream COVID-19 origins, vaccines, and public health actors; his assertions have been carried in outlets rang...
As of the sources provided through mid‑2025, thimerosal (a mercury‑based preservative) had been largely removed from most U.S. childhood vaccines and was used mainly in some seasonal influenza vaccine...
The first recombinant hepatitis B vaccine was approved by the FDA on July 23, 1986, replacing earlier plasma‑derived products . Sources show an earlier FDA action approving a hepatitis B vaccine in De...
Clinical reporting on the 2025 updated COVID-19 boosters consistently says the most common reactions were local arm pain and systemic, short-lived symptoms such as fatigue, headache, muscle aches and ...
Clinical trials and product information show Prevnar 20 (pneumococcal 20‑valent conjugate vaccine) is generally well tolerated; the most common reactions after a dose are injection‑site pain, muscle p...
Vaccination efforts have substantially reduced severe COVID-19 outcomes in the U.S.: studies and public-health surveillance show vaccines lowered hospitalizations and deaths—e.g., COVID still caused a...
A single, widely-circulated interpretation — that “a 2019 study found pneumococcal vaccination increased pneumonia risk” — does not match the bulk of available reporting. Population and trial evidence...
Unapproved “detox” regimens promoted for vaccine side effects can pose health risks, especially if they delay medical care or involve untested ingredients; mainstream public-health sources emphasize t...
Older adults (65+) are urged to get updated COVID-19 vaccines because they remain most at risk for severe outcomes; vaccine effectiveness against hospitalization in immunocompetent adults ≥65 was abou...
Updated COVID-19 vaccines introduced for 2024–2025 and adjusted again for 2025 target recent Omicron descendants (JN.1, KP.2, LP.8.1 and related lineages) and provide clear protection against severe o...
Available public reporting through mid‑2025 shows COVID‑19 hospitalization rates remain highest in the oldest adults (≥75 years) and infants (<6 or <12 months), and that vaccinated people—especially t...
Major, peer-reviewed and public-health sources in the provided set report that COVID-19 vaccines reduce severe illness, hospitalization and death and that researchers continue to study longer-term out...
Updated 2025–2026 COVID-19 boosters most commonly cause short-lived, mild-to-moderate reactions such as injection‑site pain, fatigue, fever, chills and headache; these are described in multiple patien...
Prevnar 20 (PCV20) is recommended as a single dose for adults 65 and older and is promoted as providing “lasting protection” against 20 pneumococcal serotypes , but published sources do not provide a ...